{"nct_id":"NCT04210115","title":"Study of Pembrolizumab (MK-3475) Versus Placebo in Participants With Esophageal Carcinoma Who Are Receiving Chemotherapy and Radiation Therapy (MK-3475-975/KEYNOTE-975)","status":"ACTIVE_NOT_RECRUITING","status_verified_date":"2024-11","start_date":"2020-02-28","start_date_type":"ACTUAL","primary_completion_date":"2027-02-01","primary_completion_date_type":"ESTIMATED","completion_date":"2027-02-01","completion_date_type":"ESTIMATED","phases":["PHASE3"],"tickers":["MRK"]}